期刊文献+

介入治疗内在性子宫内膜异位症的临床疗效观察 被引量:2

Observation of clinical curative effect in the patients with internal endometriosis by interventionaltherapy
原文传递
导出
摘要 目的探讨内在性子宫内膜异位症的介入治疗效果。方法采用Seldinger技术,对34例内在性子宫内膜异位症患者行双侧子宫动脉栓塞术,术后观察患者月经量、痛经程度、贫血、子宫及病灶体积的变化情况。结果随访1~3年,术后月经量较术前平均减少59.1%(P〈O.05),痛经症状明显缓解28例(82.4%,28/34)。所有贫血病例血红蛋白恢复至正常;子宫体积较术前平均缩小43.8%(P〈0.05),病灶明显缩小或消失。超声检查显示子宫肌层及病灶血流信号明显减少。结论内在性子宫内膜异位症的介入治疗效果优良,症状改善显著。 Objective To explore the curative effect in the patients with internal endometriosis by interventional therapy. Methods Using Seldinger technique, 34 cases with internal endometriosis wereperformed bilateral uterine artery embalization. Observed postoperative menstrual quantity, dysmenorrhea degree, anemia and the change of the volume of uterine lesions. Results All the patients were followed up for 1-3 years, menstrual quantity average decreased of 59.1% (P 〈 0.05 ), the symptoms of dysmenorrhea was significantly eased in 28 cases (82.4%, 28/34). All the patients of anemia haemoglobin were back to normal, volume of uterus average reduced 43.8%(P 〈 0.05), lesion was obviously smaller or disappear. Ultrasonography showed myometrium and blood flow signal of lesion was obviously reduced. Conclusion Internal endometriosis by interventional therapy can get good results, symptoms improve significantly.
出处 《中国医师进修杂志》 2012年第3期8-10,共3页 Chinese Journal of Postgraduates of Medicine
关键词 子宫内膜异位症 栓塞 胆固醇 介入治疗 Endometriosis Embolism,cholesterol Interventional therapy
  • 相关文献

参考文献9

  • 1Bergeron C, Amant F, Ferenezy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol, 2006,20 (4) : 511-521.
  • 2Vercellini P,Vigani- P,Somigliana E,et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol, 2006,20(4) : 465-477.
  • 3Yang JH,Wu MY,Chen CD,et al. Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod, 2007,22(4 ) : 945-952.
  • 4Leyendecker G,Wildt L,Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet, 2009,280(4) : 529-538.
  • 5Levgur M. Therapeutic options for adenomyosis: a review. Arch Gynecol Obstet, 2007,276 ( 1 ) : 1-15.
  • 6Rabinovici J,Stewart EA. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol, 2006,20 (4) : 617-636.
  • 7江小香,项双卫.子宫腺肌病的治疗现况[J].国际妇产科学杂志,2010,37(5):355-358. 被引量:13
  • 8宋誌.子宫内膜异位症的保守手术联合药物治疗[J].天津药学,2010,22(2):46-47. 被引量:3
  • 9朱春,杨军,陈向宇,刘伟.子宫腺肌病介入治疗初探[J].介入放射学杂志,2006,15(3):183-185. 被引量:9

二级参考文献29

  • 1高瑜,郝敏.子宫内膜异位症药物及生物治疗的研究进展[J].国外医学(妇产科学分册),2004,31(3):176-178. 被引量:4
  • 2石红建,黄优华,徐强,孙军,沈涛,周华明,蒋磊,陈其英.海藻酸钠微球(KMG)经子宫动脉栓塞治疗子宫肌瘤的初步应用[J].介入放射学杂志,2004,13(6):559-559. 被引量:9
  • 3Saleh A,Tulandi T.Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration.Fertil Steril,1999,72:322.
  • 4Albrzi S,Momtohan M,Parsanezhad M B,et al.Aprospective,randomizeds study comparing laparascopic ovarian cystectomy versus fenestration and coagulationin patients with endometriomas.Fertil Sreril,2004,82(6):1633.
  • 5Bergeron C,Amant F,Ferenczy A.Pathology and physiopathology of adenomyosis[J].Best Pract Res Clin Obstet Gynaecol,2006,20(4):511-521.
  • 6Vercellini P,Viganò P,Somigliana E,et al.Adenomyosis:epidemiological fac-tors[J].Best Pract Res Clin Obstet Gynaecol,2006,20(4):465-477.
  • 7Yang JH,Wu MY,Chen CD,et al.Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis[J].Hum Reprod,2007,22(4):945-952.
  • 8Leyendecker G,Wildt L,Mall G.The pathophysiology of endometriesis and adenomyosis:tissue injury and repair[J].Arch Gynecol Obstet,2009,280(4):529-538.
  • 9Levgur M.Therapeutic options for adenomyosis:a review[J].Arch Gynecol Obstet,2007,276(1):1-15.
  • 10Ueki K,Kumagai K.Yamashita H,et al.Expression of apoptosisrelated proteins in adenomyotic uteri treated with danazol and GnRH agonists[J].Int J Gynecol Pathol,2004,23(3):248-258.

共引文献22

同被引文献37

  • 1邢淑兰.微波治疗痛经63例疗效观察[J].中国医药指南,2008,6(15):296-297. 被引量:1
  • 2谢华,封全灵.缩宫素受体与子宫内膜异位症疼痛的相关研究[J].河南职工医学院学报,2007,19(2):121-123. 被引量:1
  • 3Shrestha A. Risk factors for adenomyosis. J Nepal Health Res Counc, 2012,10(22) :229-233.
  • 4Naphatthalung W, Cheewadhanaraks S. Prevalence of endometriosis among patients with adenomyosis and/or myoma uteri scheduled for a hysterectomy. J Med Assoc Thai, 2012,95 (9) : 1136-1140.
  • 5Sangi-Haghpeykar H,Poindexter AN 3rd. Epidemiology of endometriosis among parous women. Obstet Gynecol,1995,85 (6) :983-992.
  • 6Romanek K,Bartuzi A,Bogusiewicz M,et al. Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas. Ginekol Pol, 2010,81 ( 9 ) : 678-680.
  • 7Yeniel O, Cirpan T, Ulukus M, et al. Adenomyosis :prevalence, risk factors, symptoms and clinical findings. Clin Exp Obstet Gynecol, 2007,34(3) : 163-167.
  • 8Braaten KP, Benson CB, Maurer R,et al. Malpositioned intrauterine contraceptive devices: risk factors, outcomes, and future pregnancies. Obstet Gynecol, 2011,118(5 ) : 1014-1020.
  • 9王素芳.美洛昔康配合米非司酮治疗子宫内膜异位症痛经的疗效观察[J].中国优生优育,2014,200):180-181.
  • 10尹围英.浅谈痛经的病因、临床表现及治疗[J].(中旬刊),2014,24(1):76-77.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部